Skip to content
Menu
Network
Sub-Menu
Browse by Subject
Browse by Publisher
Join the Network
Get Started
Subscribe
Support
Contact Us
Search
Close
Enter Search Terms
Search
Camille Vermosen
ID:
1b83ac99-2619-30fb-68c4
/
Claimed Record
/
Organization:
Arnold & Porter Kaye Scholer LLP
Published Works
8 articles
EU AI Act Omnibus: Provisional Deal Announced – Initial Reflections for Life Sciences Companies
BioSlice Blog ·
May 7, 2026
cite
CJEU rules on GDPR access rights and abuse of rights: what the Brillen Rottler judgment means for life sciences companies
BioSlice Blog ·
March 25, 2026
cite
EDPB/EDPS Joint Opinion on the European Biotech Act Proposal: Key Data Protection Implications for Pharma and Life Sciences
BioSlice Blog ·
March 19, 2026
cite
EU Digital Omnibus: What the Proposed Reforms Mean for Pharma and MedTech
BioSlice Blog ·
February 26, 2026
cite
UK’s Data (Use and Access) Act: What Life Sciences Companies Need to Know
BioSlice Blog ·
February 5, 2026
cite
Previous
1
2
Next
Practice Areas
Health Care and Life Sciences
Jurisdictions
Europe
United Kingdom
